Sterling Capital Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Other funds holding DTIL
LCM
Sterling Capital Management's DTIL Position: Q3 2026 in Review
Sterling Capital Management reduced its Precision BioSciences (DTIL) stake by 2.3% in Q3 2026, selling an estimated $83 and leaving 473 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3066.
Sterling Capital Management first reported a position in DTIL in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.8K in Q2 2026. 109 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.
- Sterling Capital Management held 473 shares of Precision BioSciences worth $2.96K as of Q3 2026.
- Sterling Capital Management sold 11 Precision BioSciences shares in Q3 2026, an estimated $83.
- Precision BioSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #3066 holding.
- Sterling Capital Management first reported a position in Precision BioSciences in Q2 2026 and has held it in 2 quarters since.
- Sterling Capital Management's Precision BioSciences position peaked at $3.8K in Q2 2026.
- 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.